The MD is manufactured by B-ON, and the company asserts that the device can measure a user's electrocardiogram (EKG) activity, blood pressure, heart rate, blood oxygen levels and body temperature, at a 95 percent rate accuracy.

The teams' former medic, who is currently facing a fit-to-practise tribunal, paints a stark picture of the gold-medal factory across 66 pages of eye-opening claims within his written defence, which was disclosed over the weekend.

Flashpoint Batley: Anti-racism protesters hold rally against...

Mr Hancock was today accused of 'sh**ging on the taxpayer' after it was revealed he took his mistress to the G7 summit and claims they may have started their affair a year ago with the shamed Tory who has abandoned his wife Martha and is said to.

Mr Hancock was today accused of 'sh**ging on the taxpayer' after it was revealed he took his mistress to the G7 summit and claims they may have started their affair a year ago with the shamed Tory who has abandoned his wife Martha and is said to.

Mr Hancock was today accused of 'sh**ging on the taxpayer' after it was revealed he took his mistress to the G7 summit and claims they may have started their affair a year ago with the shamed Tory who has abandoned his wife Martha and is said to.

Mr Hancock was today accused of 'sh**ging on the taxpayer' after it was revealed he took his mistress to the G7 summit and claims they may have started their affair a year ago with the shamed Tory who has abandoned his wife Martha and is said to.

Nicholas Hewlett, head of St Dunstan's College private school in southeast London, said staff were worried by a 'righteous generation' of children who were looking for their teachers to 'trip up' on even 'small, persistent slights'.

The teams' former medic, who is currently facing a fit-to-practise tribunal, paints a stark picture of the gold-medal factory across 66 pages of eye-opening claims within his written defence, which was disclosed over the weekend.

Although the company will continue to pursue "higher-risk, high reward" drug candidates such as pegilodecakin, these will be a smaller part of the portfolio in the future, said Chief Scientific Officer Daniel Skovronsky.